- Mar 17/24
Streamlining the path from lab to market with 3D bioprinting - Mar 15/24
Machine learning classifier accelerates the development of cellular immunotherapies - Mar 15/24
Cell and gene therapy investment: evolution and future outlook on investor perspectives - Mar 14/24
Often overlooked stem cells hold hidden powers for blood disease treatments - Mar 14/24
SS National Lab-sponsored study tests a novel gene therapy for vision loss - Mar 14/24
Team performs the first gene therapy tests in a whole human liver - Mar 13/24
“Dual-target” cell therapy appears to shrink brain tumours, research finds - Mar 13/24
Novel CAR-T for glioblastoma induced “dramatic” responses in early trial - Mar 13/24
Genetic tuning: The next frontier of genetic medicine - Mar 13/24
New Canada Research Chairs advance research in regenerative medicine, sustainable housing and more - Mar 13/24
UBC and the B.C. biotech boom - Mar 12/24
Studying cells and gels to regenerate spinal disks - Mar 12/24
Scientists search for new ways to fix gene therapy’s fertility problem - Mar 12/24
Cellares unveils clinically-compliant cell therapy manufacturing platform - Mar 11/24
CAR-T shows “superior outcomes” in adults with post-transplant relapsed leukemia - Mar 11/24
First cell therapy for solid tumours heads to the clinic: what it means for cancer treatment
- Mar 10/24
- Study: Researchers demonstrate prime editing as option to correct many disease-causing genetic mutation
- Mar 9/24
B.C. biotech boom: Vancouver looks to join the global big leagues of modern medicine - Mar 9/24
Scientists transform skin cells into functional eggs in mice - Mar 8/24
CAR T-cell therapy shows activity in subgroup of brain tumour patients - Mar 7/24
Woman given a new 3D-printed windpipe in a world-first - Mar 7/24
Addressing CAR T challenges: Enhancing collaboration for patient care - Mar 7/24
Luigi Naldini: Gene therapy no longer a “dream” but big pharma must step up - Mar 7/24
The biggest challenges facing broader adoption of novel cell and gene therapies - Mar 7/24
Cell therapy may benefit certain patients with heart failure, reduced ejection fraction - Mar 6/24
Novel stem-cell therapy continues to show promise for Parkinson’s disease - Mar 6/24
Combining novel biomaterial and microsurgery might enable faster tissue recovery - Mar 6/24
$82m investment in cell therapies for neurological diseases - Mar 5/24
World-first trial of regenerative hearing drug is successfully completed - Mar 5/24
Turning skin cells into limb cells sets the stage for regenerative therapy - Mar 5/24
Study paves the way for “off-the-shelf” cervical cancer cell therapy - Mar 4/24
Science continues to outpace commercialization of cell and gene therapies - Mar 4/24
The decades-long quest for lab-grown organs - Mar 1/24
Overcoming the challenges of gene therapy - Mar 1/24
FDA details expectations for gene-editing therapy IND applications - Mar 1/24
Accelerating progress in cell and gene therapy - Feb 29/24
Development of T-cell lymphoma “very serious” but “very rare” after CAR T-cell therapy - Feb 29/24
The fight to pay for gene therapy - Feb 29/24
Biotech launches with $82 million for Parkinson’s cell therapy - Feb 28/24
“Bad” cholesterol gene silenced without altering the DNA sequence - Feb 28/24
Stealthy stem cells to treat disease - Feb 28/24
How cell and gene therapy manufacturing will evolve in 2024 - Feb 28/24
Using gravity to separate T cells could speed up cancer treatment - Feb 27/24
Targeting pathological proteins: gene therapy for neurodegenerative diseases - Feb 27/24
A new generation of drug therapies requires new business strategies - Feb 27/24
Internal documents shed new light on Sarepta FDA decision, which top agency official says was “exceptional” - Feb 26/24
Innovative therapy targets and destroys leukemia stem cells - Feb 23/24
CAR-T recipients report higher rates of “potentially serious” toxicities - Feb 23/24
Topical gene therapy improves ocular complications of dystrophic epidermolysis bullosa - Feb 22/24
Long-term CAR-T data bolsters autoimmune argument - Feb 22/24
Exploring complement system response to adeno-associated virus vector gene therapy - Feb 21/24
What can super-healing species teach us about regeneration? - Feb 21/24
Invariant natural killer T-cell therapy: a promising treatment for acute respiratory distress syndrome - Feb 21/24
Harnessing bird retrotransposon to improve gene therapy - Feb 21/24
Charles River and Pluristyx partner on human pluripotent stem cells - Feb 21/24
Combatting HIV using gene therapy - Feb 21/24
Meet the fetal surgeon forging CRISPR’s next frontier: curing diseases in the womb - Feb 20/24
Making moves toward cell therapy for diabetes - Feb 20/24
Cancer therapy approved by FDA uses body’s own cells as a “living drug” - Feb 20/24
Gene therapy makers struggle to find patients for miracle cures - Feb 19/24
Revolutionizing medicine: Scientists create bone marrow organoids from human stem cells - Feb 19/24
Bayer AG and AskBio initiate Phase II trial of AB-1002 gene therapy for congestive heart failure - Feb 19/24
Stem cells grown in labs for experimental therapies pose a cancer risk